› Forums › Cutaneous Melanoma Community › MSK PD-1 Complete Response Survival and Relapse Study
- This topic has 1 reply, 1 voice, and was last updated 4 years, 10 months ago by
ed williams.
- Post
-
- March 25, 2020 at 8:38 pm
Not sure if this is old news or not. Looked back a little and didn’t see anything on his MSK study.
Viewing 0 reply threads
- Replies
-
-
- March 25, 2020 at 8:45 pm
It has been showing up here and there over the last few months. Most of these patients were on Pembro and were probably part of keynote 006 trial. Would be nice if all of the Pd-1 patients data went into some kind of central Bristol Myer Squibb system or Merck system and they actual shared the information to keep us all up to date!!! Maybe some day drug companies will be responsible for recording survival past the trials and into the real world. Thanks for posting!!!Ed
-
Viewing 0 reply threads
Tagged: cutaneous melanoma
- You must be logged in to reply to this topic.